• Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Deutsche Health and Wellness Fund

+ Add to Watchlist

SCHLX:US

43.32 USD 0.23 0.53%

As of 09:29:30 ET on 12/19/2014.

Snapshot for Deutsche Health and Wellness Fund (SCHLX)

Year To Date: +30.75% 3-Month: +9.95% 3-Year: +33.14% 52-Week Range: 32.74 - 43.32
1-Month: +4.63% 1-Year: +33.71% 5-Year: +21.75% Beta vs MXWO: 0.97

Mutual Fund Chart for SCHLX

No chart data available.
  • SCHLX:US 43.32
  • 1M
  • 1Y
Interactive SCHLX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for SCHLX

Deutsche Health and Wellness Fund is an open-end fund incorporated in the USA. The Fund seeks long-term growth of capital. The Fund invests at least 80% of its assets in the health care sector. This includes pharmaceuticals, biotechnology, medical products and supplies, and health care services.

Inception Date: 03-02-1998 Telephone: 1-800-730-1313
Managers: THOMAS E BUCHER / PETER BARSA
Web Site: www.fundsus.deutscheawm.com

Fundamentals for SCHLX

NAV (on 2014-12-19) 43.32
Assets (M) (on 2014-12-19) 376.10
Fund Leveraged N
Minimum Investment 2,500.00
Minimum Subsequent Investment 50.00

Dividends for SCHLX

Dividend Type Short Term Cap Gain
Dividend Frequency Annual
Last Dividend Net (on 2014-12-12) 0.66
Dividend Yield (ttm) 7.60

Fees & Expenses for SCHLX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 0.77
Redemption Fee 2.00
12b1 Fee 0.00
Expense Ratio 1.09

Top Fund Holdings for SCHLX

Filing Date: 10/31/2014
Name Position Value % of Total
Gilead Sciences Inc 132,035 14,787,920 4.126%
Bristol-Myers Squibb Co 213,812 12,441,720 3.472%
Actavis plc 49,574 12,033,593 3.358%
Celgene Corp 107,467 11,508,641 3.211%
Johnson & Johnson 96,238 10,372,532 2.894%
Merck & Co Inc 178,380 10,335,337 2.884%
Amgen Inc 59,595 9,665,117 2.697%
AbbVie Inc 150,942 9,578,779 2.673%
Biogen Idec Inc 29,336 9,419,203 2.628%
Pfizer Inc 303,470 9,088,927 2.536%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil